Riboxin (inosine) coated tablets 200 mg. №50

$5.00

Complex treatment of ischemic heart disease (state after myocardial infarction, angina), heart rhythm disorders, intoxication with cardiac glycosides, treatment of cardiomyopathies of different Genesis , myocardiodystrophy (against the background of heavy physical exertion, infectious and endocrine Genesis), myocarditis; liver diseases (hepatitis, cirrhosis, fatty liver dystrophy); urocoproporphyria.

Category: Manufacturer: Ukraine

Description

Release form, composition
Riboxin is produced in the form of yellow coated tablets with beveled edges.
The composition of 1 tablet includes inosine (riboxin) 200 mg as the main component, as well as additional substances: potato starch, methylcellulose, crystalline sugar, stearic acid, tropeolin 0, polysorbate 80, titanium dioxide.
5 blister packs in a cardboard box each containing 10 tablets.

Pharmacological properties
Riboxin belongs to the group of cardiological agents.
Due to its properties, the drug improves metabolic processes in the myocardium, increases the strength of heart contractions and the activity of a number of enzymes of the Krebs cycle, promotes more complete relaxation of the myocardium in diastole. Improves blood supply to tissues and coronary blood supply, activates tissue regeneration (in particular myocardium, intestinal mucosa and stomach).

Indications for use
Riboxin is used as part of complex treatment for:

  • ischemic heart disease (heart rhythm disturbances, angina pectoris);
  • glycosidic intoxication;
  • cardiomyopathies of various origins;
  • myocarditis;
  • peptic ulcer of the stomach and duodenum;
  • liver diseases (chronic and acute hepatitis, drug and alcoholic liver damage, liver cirrhosis and fatty liver disease);
  • urokoproporphyria.

Contraindications
The drug Riboxin is contraindicated for use in the presence of diseases such as gout, hyperuricemia and renal failure. Also, the drug is not used by persons with increased susceptibility to the components of the drug and in childhood.

Pregnancy and breastfeeding period
The use of the drug Riboxin during pregnancy and lactation is contraindicated.

Mode of application
The drug Riboxin is used before meals, without chewing and drinking plenty of water.
The recommended dose for adult patients is 600-2400 mg per day, a more accurate dosage is set by the doctor for each patient individually.
At the beginning of treatment, 1 tablet is prescribed 3-4 times a day (600-800 mg), with good tolerance, the dose is gradually increased over 2-3 days, 2 tablets 3 times a day (1200 mg), if there is a need for 4 tablets 3 times a day (2400 mg).
The duration of therapy is 1-3 months.

Overdose
An overdose of Riboxin is accompanied by the following symptoms: allergic reactions, increased manifestations of side reactions. In case of drug intoxication, symptomatic treatment is used.

Adverse reactions
The use of the drug Riboxin very rarely causes side effects, but sometimes it is possible: itching, rash, skin flushing, an increase in the concentration of uric acid in the blood and tachycardia. With prolonged use or in high dosages, exacerbation of gout may occur.

Storage conditions
To store the drug Riboxin, you should adhere to such simple conditions: the temperature is not more than + 25 ° C, in a dark and dry place, as well as as far as possible from children.
The shelf life of the tablets is 4 years from the date of production.